removab
neovii biotech gmbh - catumaxomab - ascites; cancer - muut antineoplastiset aineet - removab on tarkoitettu pahanlaatuisten ascitesin intraperitoneaaliseen hoitoon potilailla, joilla on epcam-positiiviset karsinoomat, joissa standardihoitoa ei ole saatavilla tai ei enää ole mahdollista.
qaialdo
nova laboratories ireland limited - spironolaktoni - edema; heart failure; liver cirrhosis; ascites; nephrotic syndrome; hyperaldosteronism; essential hypertension - antihypertensives and diuretics in combination - in the management of refractory oedema associated with congestive cardiac failure; hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, diagnosis and treatment of primary aldosteronism, essential hypertension. neonates, children and adolescents should only be treated under guidance of a paediatric specialist (see sections 5. 1 ja 5.
citrafleet jauhe oraaliliuosta varten, annospussi
casen recordati, s.l. - citric acid anhydrous, magnesium oxide, light, sodium picosulfate - jauhe oraaliliuosta varten, annospussi - natriumpikosulfaatti
citrafleet oraaliliuos
casen recordati, s.l. - citric acid anhydrous, magnesium oxide, light, sodium picosulfate - oraaliliuos - natriumpikosulfaatti
zavedos 5 mg kapseli, kova
pfizer oy - idarubicin hydrochloride - kapseli, kova - 5 mg - idarubisiini
casodex 50 mg tabletti, kalvopäällysteinen
laboratoires juvise pharmaceuticals - bicalutamide - tabletti, kalvopäällysteinen - 50 mg - bikalutamidi
casodex 150 mg tabletti, kalvopäällysteinen
laboratoires juvise pharmaceuticals - bicalutamide - tabletti, kalvopäällysteinen - 150 mg - bikalutamidi
prilactone vet 10 mg purutabletti
ceva santÉ animale - spironolactone - purutabletti - 10 mg - spironolaktoni
prilactone vet 50 mg purutabletti
ceva santÉ animale - spironolactone - purutabletti - 50 mg - spironolaktoni
prilactone vet 100 mg purutabletti
ceva santÉ animale - spironolactone - purutabletti - 100 mg - spironolaktoni